{"id":3235,"date":"2017-02-01T21:40:00","date_gmt":"2017-02-02T02:40:00","guid":{"rendered":"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/"},"modified":"2018-05-30T17:09:56","modified_gmt":"2018-05-30T21:09:56","slug":"tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns","status":"publish","type":"tribe_events","link":"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/","title":{"rendered":"Grand Rounds &#8211; Tolerogenic Vaccination as a Myelin-Specific Therapy for Autoimmune Demyelinating Disease of the CNS"},"content":{"rendered":"<div>\n<h2>Tolerogenic Vaccination as a Myelin-Specific Therapy for Autoimmune Demyelinating Disease of the CNS<\/h2>\n<h3>Mark D. Mannie, PhD<\/h3>\n<p>The Brody School of Medicine<br \/>East Carolina University<\/p>\n<p><strong>Objectives:<\/strong><\/p>\n<ul>\n<li>Describe experimental strategies of tolerogenic vaccination for induction of FOXP3<sup>+<\/sup> regulatory T cells.<\/li>\n<li>Discuss properties by which cytokines IFN-\u03b2 and GM-CSF can be used to drive regulatory T cell responses. <\/li>\n<li>Explain mechanisms of \u2018infectious\u2019 tolerance regarding induction of polyclonal tolerance to the CNS.<\/li>\n<\/ul>\n<p style=\"margin: 0px 0px 1em; padding: 0px; color: rgb(50, 50, 50); letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; word-spacing: 0px; text-stroke-width: 0px; background-color: rgb(255, 255, 255); \"><strong style=\"margin: 0px; padding: 0px; color: rgb(0, 0, 0); \">February 2, 2017, 8 &#8211; 9 am<\/strong><br style=\"margin: 0px; padding: 0px; \"\/>CG222, Sanofi-Aventis Conference Center, NCCH Room #1<\/p>\n<p style=\"margin: 0px 0px 1em; padding: 0px; color: rgb(50, 50, 50); letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; word-spacing: 0px; text-stroke-width: 0px; background-color: rgb(255, 255, 255); \"><em style=\"margin: 0px; padding: 0px; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; word-spacing: 0px; color: black; \">Sponsored by the School of Medicine of The University of North Carolina at Chapel Hill.<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p><!-- description --> <\/p>\n<p class='lead'>Mark D. Mannie, PhD presents &#8220;Tolerogenic Vaccination as a Myelin-Specific Therapy for Autoimmune Demyelinating Disease of the CNS&#8221;<\/p>\n","protected":false},"author":58435,"featured_media":0,"template":"","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","_tribe_events_status":"","_tribe_events_status_reason":"","_tribe_events_is_hybrid":"","_tribe_events_is_virtual":"","_tribe_events_virtual_video_source":"","_tribe_events_virtual_embed_video":"","_tribe_events_virtual_linked_button_text":"","_tribe_events_virtual_linked_button":"","_tribe_events_virtual_show_embed_at":"","_tribe_events_virtual_show_embed_to":[],"_tribe_events_virtual_show_on_event":"","_tribe_events_virtual_show_on_views":"","_tribe_events_virtual_url":"","footnotes":"","_links_to":"","_links_to_target":""},"tags":[8,7],"tribe_events_cat":[],"class_list":["post-3235","tribe_events","type-tribe_events","status-publish","hentry","tag-department-of-neurology","tag-grand-rounds","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Grand Rounds - Tolerogenic Vaccination as a Myelin-Specific Therapy for Autoimmune Demyelinating Disease of the CNS | Department of Neurology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Grand Rounds - Tolerogenic Vaccination as a Myelin-Specific Therapy for Autoimmune Demyelinating Disease of the CNS | Department of Neurology\" \/>\n<meta property=\"og:description\" content=\"Mark D. Mannie, PhD presents &quot;Tolerogenic Vaccination as a Myelin-Specific Therapy for Autoimmune Demyelinating Disease of the CNS&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Neurology\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UNCNeurology\/\" \/>\n<meta property=\"article:modified_time\" content=\"2018-05-30T21:09:56+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@UNCneurology\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/\",\"url\":\"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/\",\"name\":\"Grand Rounds - Tolerogenic Vaccination as a Myelin-Specific Therapy for Autoimmune Demyelinating Disease of the CNS | Department of Neurology\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/#website\"},\"datePublished\":\"2017-02-02T02:40:00+00:00\",\"dateModified\":\"2018-05-30T21:09:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/neurology\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\/\/www.med.unc.edu\/neurology\/events\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Grand Rounds &#8211; Tolerogenic Vaccination as a Myelin-Specific Therapy for Autoimmune Demyelinating Disease of the CNS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/neurology\/\",\"name\":\"Department of Neurology\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/neurology\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/#organization\",\"name\":\"UNC Department of Neurology\",\"url\":\"https:\/\/www.med.unc.edu\/neurology\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.med.unc.edu\/neurology\/wp-content\/uploads\/sites\/716\/2018\/05\/new_neurology_logo.jpg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/neurology\/wp-content\/uploads\/sites\/716\/2018\/05\/new_neurology_logo.jpg\",\"width\":1657,\"height\":601,\"caption\":\"UNC Department of Neurology\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/UNCNeurology\/\",\"https:\/\/x.com\/UNCneurology\",\"https:\/\/www.instagram.com\/unc_neurology\/\",\"https:\/\/www.linkedin.com\/in\/unc-neurology\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Grand Rounds - Tolerogenic Vaccination as a Myelin-Specific Therapy for Autoimmune Demyelinating Disease of the CNS | Department of Neurology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/","og_locale":"en_US","og_type":"article","og_title":"Grand Rounds - Tolerogenic Vaccination as a Myelin-Specific Therapy for Autoimmune Demyelinating Disease of the CNS | Department of Neurology","og_description":"Mark D. Mannie, PhD presents \"Tolerogenic Vaccination as a Myelin-Specific Therapy for Autoimmune Demyelinating Disease of the CNS\"","og_url":"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/","og_site_name":"Department of Neurology","article_publisher":"https:\/\/www.facebook.com\/UNCNeurology\/","article_modified_time":"2018-05-30T21:09:56+00:00","twitter_card":"summary_large_image","twitter_site":"@UNCneurology","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/","url":"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/","name":"Grand Rounds - Tolerogenic Vaccination as a Myelin-Specific Therapy for Autoimmune Demyelinating Disease of the CNS | Department of Neurology","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/neurology\/#website"},"datePublished":"2017-02-02T02:40:00+00:00","dateModified":"2018-05-30T21:09:56+00:00","breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/neurology\/event\/tolerogenic-vaccination-as-a-myelin-specific-therapy-for-autoimmune-demyelinating-disease-of-the-cns\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/neurology\/"},{"@type":"ListItem","position":2,"name":"Events","item":"https:\/\/www.med.unc.edu\/neurology\/events\/"},{"@type":"ListItem","position":3,"name":"Grand Rounds &#8211; Tolerogenic Vaccination as a Myelin-Specific Therapy for Autoimmune Demyelinating Disease of the CNS"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/neurology\/#website","url":"https:\/\/www.med.unc.edu\/neurology\/","name":"Department of Neurology","description":"","publisher":{"@id":"https:\/\/www.med.unc.edu\/neurology\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/neurology\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.med.unc.edu\/neurology\/#organization","name":"UNC Department of Neurology","url":"https:\/\/www.med.unc.edu\/neurology\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/neurology\/#\/schema\/logo\/image\/","url":"https:\/\/www.med.unc.edu\/neurology\/wp-content\/uploads\/sites\/716\/2018\/05\/new_neurology_logo.jpg","contentUrl":"https:\/\/www.med.unc.edu\/neurology\/wp-content\/uploads\/sites\/716\/2018\/05\/new_neurology_logo.jpg","width":1657,"height":601,"caption":"UNC Department of Neurology"},"image":{"@id":"https:\/\/www.med.unc.edu\/neurology\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/UNCNeurology\/","https:\/\/x.com\/UNCneurology","https:\/\/www.instagram.com\/unc_neurology\/","https:\/\/www.linkedin.com\/in\/unc-neurology\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/tribe_events\/3235","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/users\/58435"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/tribe_events\/3235\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/media?parent=3235"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/tags?post=3235"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/tribe_events_cat?post=3235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}